Evidence mapPaperPMID 40869415Full record

ReviewInternational journal of molecular sciences2025

Vertebrate and Invertebrate Animal Models for the Study of Down Syndrome.

Ann-Charlotte Granholm

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ann-Charlotte GranholmDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-9685-7599

Funding

Exosome biology in Alzheimer's disease and concussionR01AG071228 · UNIVERSITY OF COLORADO DENVER · 2025 to 2025
$695k
BrightFocus Foundation CA2018010Lejeune Foundation GRT-2023b/2277NIA NIH HHS R01 AG071228NIA NIH HHS RF1 AG061566NIH HHS 1U24AG092191-01NIH HHS R01AG061566
6 · The paper itself

Abstract

Down syndrome (DS) is the most common survivable chromosome trisomy, with an incidence of about 1 in 600-700 births. Consequences of chromosome 21 trisomy include developmental delays, congenital cardiac abnormalities, skeletal abnormalities, and age-related dementia of the Alzheimer's disease (AD) type. Up to 90% of individuals with DS develop dementia symptoms in their 40s or 50s. Because the biological mechanisms involved in DS-related developmental and age-related pathology are less known, animal models consisting of both lower-order and higher-order animals have been developed. We here review the most pertinent and well-studied DS animal models including models developed in

Indexed as

Disease Models, AnimalDown SyndromeAnimalsCaenorhabditis elegansHumansInvertebratesMiceVertebratesZebrafishAlzheimer’s diseaseanimal modelschromosome trisomyDown syndromeneurodegeneration

Identifiers

PMID40869415
PMCPMC12386676

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.